Today, AdvaMed President and CEO Scott Whitaker applauded the White House’s Request for Information on policies to sustain diagnostic test manufacturing for COVID-19. This comes as AdvaMedDx, a division of AdvaMed that represents more than 75 diagnostic companies, and other partners have encouraged the Biden Administration to do more to maintain COVID-19 test manufacturing capacity and implement public-private agreements to shore up supply.
